S. 5046 · 118th Congress
FDA Modernization Act 3.0
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Passed the Senate without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 118th Congress ended.
D
BookerSponsor9 cosponsors · 3 D, 5 R, 1 I
D
Blumenthal
MB
R
Braun
AK
I
King
JK
R
Kennedy
BL
D
Luján
RP
R
Paul
ES
R
Schmitt
SW
D
Whitehouse
RM
R
Marshall8 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- Senate Introduced Sep 12, 2024
- Senate Passed Dec 12, 2024
This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug.
What it does: CRS summary · Passed Senate · Dec 12, 2024
FDA Modernization Act 3.0
This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug.
The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications, and may make other changes to the regulations as appropriate.
The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: FDA Modernization Act 3.0
Latest action (Dec 16, 2024): Held at the desk.
Policy area: Health · Origin: Senate · Introduced: Sep 12, 2024
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
- Senate Introduced Sep 12, 2024
- Senate Passed Dec 12, 2024
No recorded floor vote found.